Evaluation of bone mineral density in Iranian HIV/AIDS patients

Acta Medica Iranica

Volumn 49, Issue 7, 2011, Pages 460-467

  Badie, Banafsheh Moradmand ^a   Soori, Tahereh ^b   Kheirandish, Parastoo ^a   Izadyar, Saeed ^b   SeyedAlinaghi, SeyedAhmad ^a   Foroughi, Maryam ^a   Rostamian, Alireza ^b   Mohraz, Minoo ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

AIDS; Antiretroviral drugs; Bone Mineral Density; HIV; Osteopenia; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; RISK ASSESSMENT; RISK FACTOR;

ADULT; BONE DENSITY; FEMALE; HIV INFECTIONS; HUMANS; IRAN; MALE; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE;

EID: 80053236582     PISSN: 00446025     EISSN: 17359694     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, Eron JJ Jr, Feinberg JE, Balfour HH Jr, Deyton LR, Chodakewitz JA, Fischl MA. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med 1997;337(11):725-33.
2. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338(13):853-60.
3. Brinkman K, ter Hofstede HJ, Burger DM, Smeitink JA, Koopmans PP. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 1998;12(14):1735-44.
4. Tebas P. Osteopenia, osteoporosis, and other bone problems in HIV-infected individuals. Physicians' Res Net 6(3); 2001:12-7.
5. Grinspoon SK, Bilezikian JP. HIV disease and the endocrine system. N Engl J Med 1992;327(19):1360-5.
6. Meyer D, Behrens G, Schmidt RE, Stoll M. Osteonecrosis of the femoral head in patients receiving HIV protease inhibitors. AIDS 1999;13(9):1147-8.
7. Stephens EA, Das R, Madge S, Barter J, Johnson MA. Symptomatic osteoporosis in two young HIV-positive African women. AIDS 1999;13(18):2605-6.
8. th International Conference on Nutrition and HIV Infection, Cannes, France, 2001.
9. Moore AL, Vashisht A, Sabin CA, Mocroft A, Madge S, Phillips AN, Studd JW, Johnson MA. Reduced bone mineral density in HIV-positive individuals. AIDS 2001;15(13):1731-3.
10. McGowan I, Cheng A, Coleman S, Johnson A, Genant H; Conference on Retroviruses and Opportunistic Infections. [online] 2001 Feb [cited 2011 Jun 15]; Program Abstract, 8th Conf Retrovir Oppor Infect Conf, Chic Ill. 4-8;8:233. Available from: URL: http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=102244412.html
11. Knobel H, Guelar A, Vallecillo G, Nogués X, Díez A. Osteopenia in HIV-infected patients: is it the disease or is it the treatment? AIDS 2001;15(6):807-8.
12. Negredo E, Gel S, Arisa ER, Rosales J, Paredes R, Del Rio L, Balague M, Johnston S, Sirera G, Tural C, Bonjoch A, Jou A, Cruz L, Clotet B; Conference on Retroviruses and Opportunistic Infections. Bone mineral density (BMD) in HIV-1-infected patients. [online] 2001 Feb [cited 2011 Jun 15]; Program Abstract, 8th Conf Retrovir Oppor Infect Conf, 2001 Chic Ill. 4-8;8:232. Available from: URL: http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=102244410.html
13. Lawal A, Engelson ES, Wang J, Heymsfield SB, Kotler DP. Equivalent osteopenia in HIV-infected individuals studied before and during the era of highly active antiretroviral therapy. AIDS 2001;15(2):278-80.
14. Thomas J, Doherty SM. HIV infection: a risk factor for osteoporosis. J Acquir Immune Defic Syndr 2003;33(3):281-91.
15. Anastos K, Lu D, Shi O, Mulligan K, Tien PC, Freeman R, Cohen MH, Justman J, Hessol NA. The association of bone mineral density with HIV infection and antiretroviral treatment in women. Antivir Ther 2007;12(7):1049-58.
16. Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, Yarasheski KE. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 2000;14(4):F63-7.
17. Paton NI, Macallan DC, Griffin GE, Pazianas M. Bone mineral density in patients with human immunodeficiency virus infection. Calcif Tissue Int 1997;61(1):30-2.
18. Mondy K, Yarasheski K, Powderly WG, Whyte M, Claxton S, DeMarco D, Hoffmann M, Tebas P. Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis 2003;36(4):482-90.
19. Chang K, Kim J, Hong S, Song Y, Lee H, Lim S; Conference on Retroviruses and Opportunistic Infections. [online] 2001 Feb [cited 2011 Jun 15]; Program Abstract, 8th Conf Retrovir Oppor Infect Conf, Chic Ill. 4-8;8:233. Available from: URL: http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=102244414.html
20. Riggs BL, Melton LJ 3rd. The prevention and treatment of osteoporosis. N Engl J Med 1992;327(9):620-7.
21. Erikson EF, Berg NJ, Graham ML, Colvard DS, Mann KG, Spelsberg TC, Riggs BL. Multiple sex steroid receptors in cultured human osteoblast-like cells. In: Christiansen C, Johansen JS, Riis BJ, editors. International Symposium on Osteoporosis, Denmark, 1987.
22. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994;843:1-129.
23. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9(8):1137-41.
24. Schambelan M, Benson CA, Carr A, Currier JS, Dubé MP, Gerber JG, Grinspoon SK, Grunfeld C, Kotler DP, Mulligan K, Powderly WG, Saag MS; International AIDS Society-USA. Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel. J Acquir Immune Defic Syndr 2002;31(3):257-75.
25. Baran DT, Faulkner KG, Genant HK, Miller PD, Pacifici R. Diagnosis and management of osteoporosis: guidelines for the utilization of bone densitometry. Calcif Tissue Int 1997;61(6):433-40.
26. Miller PD, Zapalowski C, Kulak CA, Bilezikian JP. Bone densitometry: the best way to detect osteoporosis and to monitor therapy. J Clin Endocrinol Metab 1999;84(6):1867-71.